3 ms·
It's not patents, most early insulin is off patent. Most of the barriers are regulatory and profitability. It is worth noting that bidens 35 is a copay limit,
by s1artibartfast 5y ago
It's not patents, most early insulin is off patent.
Most of the barriers are regulatory and profitability.
It is worth noting that bidens 35 is a copay limit, not a limit on what your insurance pays.
As a example for profitability, this non profit hopes to bring the total cost down to 30:
https://www.google.com/amp/s/amp.cnn.com/cnn/2022/03/03/politics/civica-insulin-affordable-drug/index.html https://www.google.com/amp/s/amp.cnn.com/cnn/2022/03/03/poli...